Market Overview

Bloomberg: GlaxoSmithKline, Qualcomm To Jointly Develop Medical Technology


According to Bloomberg, GlaxoSmithKline plc (ADR) (NYSE: GSK) and QUALCOMM, Inc. (NASDAQ: QCOM) are discussing ways to combine both companies expertise and create advances in medical technology.

Bloomberg, citing "people with knowledge of the matter," noted that GlaxoSmithKline isn't the first drugmaker to cooperate with a technology company to improve its medical products.

Meanwhile, Qualcomm announced earlier this month it plans on expanding a partnership with Novartis AG (ADR) (NYSE: NVS) to improve data aggregation on clinical trials and develop "Internet-of-things connectivity" for its inhalers.

Shares of GlaxoSmithKline were trading lower by 2.30 percent at $38.38 mid-Wednesday afternoon, while shares of Qualcomm were also lower by 2.43 percent at $44.97.

Posted-In: Bloomberg Drug companies DrumkaersBiotech News Health Care Rumors General


Related Articles (GSK + NVS)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

3 Stocks Making New 52-Week Highs

Report: McDonald's Received At Least Two Bids For A Stake In Its Japanese Unit, But High Valuation A Concern